Market
Nektar Therapeutics [NKTR] stock Initiated by B. Riley Securities analyst, price target now $4
Nektar Therapeutics [NASDAQ: NKTR] gained 3.55% or 0.02 points to close at $0.70 with a heavy trading volume of 8379456 shares. The daily chart for NKTR points out that the company has recorded -42.15% loss over the past six months. If we look at the
